Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311805 (7-(4-Fluorophenyl)-8-(7-chloro-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311771 (2-Cyclopentyl-7-(4-fluorophenyl)-8-(7-methyl-1H-in...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292056 (2-Cyclobutyl-3-(7-methyl-1H-indazol-5-yl)-5-(trifl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292057 (3-(7-Chloro-1H-indazol-5-yl)-2-cyclobutyl-5-(trifl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311848 (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311766 (2-Cyclobutyl-7-(4-fluorophenyl)-8-(7-methyl-1H-ind...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311811 (7-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-2-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292055 (7-Chloro-5-(2-cyclobutyl-5-(trifluoromethyl)-2H-py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311808 (2-(Difluoromethyl)-7-(4-fluorophenyl)-8-(7-methyl-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311806 (7-(4-Fluorophenyl)-8-(7-methyl-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292054 (5-(2-Cyclobutyl-5-(trifluoromethyl)-2H-pyrazolo[4,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311847 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292053 (3-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-5-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311810 (2-Cyclopropyl-7-(4-fluorophenyl)-8-(7-methyl-1H-in...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311768 (7-Cyclopentyl-8-(7-methyl-1H-indazol-5-yl)-2-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor 1/Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM426135 (5-[2-(4-Fluorophenyl)-8-(4-fluoro-1-piperidyl)imid...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute Curated by ChEMBL | Assay Description Negative allosteric modulation of recombinant human GluA1 flop isoform/TARPgamma2 expressed in HEK293 cells assessed as inhibition of glutamate-induc... | ACS Med Chem Lett 10: 267-272 (2019) Article DOI: 10.1021/acsmedchemlett.8b00599 BindingDB Entry DOI: 10.7270/Q26H4MRG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311849 (2-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor 1/Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM426135 (5-[2-(4-Fluorophenyl)-8-(4-fluoro-1-piperidyl)imid...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute Curated by ChEMBL | Assay Description Negative allosteric modulation of recombinant human GluA1 flop isoform/TARPgamma2 expressed in HEK293 cells assessed as inhibition of glutamate-induc... | ACS Med Chem Lett 10: 267-272 (2019) Article DOI: 10.1021/acsmedchemlett.8b00599 BindingDB Entry DOI: 10.7270/Q26H4MRG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311828 (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292061 (5-(Difluoromethyl)-2-isopropyl-3-(7-methyl-1H-inda...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292037 (2-Cyclopentyl-3-(7-methyl-1H-indazol-5-yl)-5-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311829 (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311799 (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311843 (3-Chloro-8-(7-chloro-1H-indazol-5-yl)-2-cyclopropy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311833 (8-(7-Chloro-1H-indazol-5-yl)-7-isopropyl-2-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311845 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311792 (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292065 (5,7-Bis(difluoromethyl)-2-isopropyl-3-(7-methyl-1H...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor 1/Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM426226 (5-[2-(4-Fluorophenyl)-7-(4-hydroxy-1-piperidyl)pyr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | PDB Article PubMed | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute Curated by ChEMBL | Assay Description Negative allosteric modulation of recombinant human GluA1 flop isoform/TARPgamma2 expressed in HEK293 cells assessed as inhibition of glutamate-induc... | ACS Med Chem Lett 10: 267-272 (2019) Article DOI: 10.1021/acsmedchemlett.8b00599 BindingDB Entry DOI: 10.7270/Q26H4MRG | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311793 (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311781 (8-(7-Chloro-1H-indazol-5-yl)-2,7-bis(trifluorometh...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311767 (6-(7-(4-Fluorophenyl)-2-(trifluoromethyl)-[1,2,4]t...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292052 (2-Isopropyl-3-(7-methyl-1H-indazol-5-yl)-5-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292051 (7-Chloro-5-(2-isopropyl-5-(trifluoromethyl)-2H-pyr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311850 (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311830 (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glutamate receptor 1/Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM426232 (5-[7-(4-Acetylpiperazin-1-yl)-2-(4-fluorophenyl)py...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanford Burnham Prebys Medical Discovery Institute Curated by ChEMBL | Assay Description Negative allosteric modulation of recombinant human GluA1 flop isoform/TARPgamma2 expressed in HEK293 cells assessed as inhibition of glutamate-induc... | ACS Med Chem Lett 10: 267-272 (2019) Article DOI: 10.1021/acsmedchemlett.8b00599 BindingDB Entry DOI: 10.7270/Q26H4MRG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292045 (3-(7-Chloro-1H-indazol-5-yl)-2-methyl-5-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311844 (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-3-fluor...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311769 (7-(Azetidin-1-yl)-8-(7-methyl-1H-indazol-5-yl)-2-(...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311834 (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311783 (5-(2,7-Bis(trifluoromethyl)-[1,2,4]triazolo[1,5-a]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311775 (8-(7-Chloro-1H-indazol-5-yl)-2,7-bis(trifluorometh...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311831 (7-Chloro-5-[2-cyclopropyl-7-(trifluoromethyl)imida...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311754 (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311824 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311846 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292049 (3-(7-Chloro-1H-indazol-5-yl)-2-ethyl-5-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292050 (5-(2-Isopropyl-5-(trifluoromethyl)-2H-pyrazolo[4,3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311851 (2-Ethyl-8-(7-methyl-1H-indazol-5-yl)-7-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 160 total ) | Next | Last >> |